Institutional investors purchased a net $1.5 million shares of OPK during the quarter ended March 2015. This may signal that the smart money is gaining interest in this company as the 17.95% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GOLDMAN SACHS INTERNATIONAL Bought 2.0 Million shares of OPKO Health Inc
RENAISSANCE TECHNOLOGIES LLC Bought 1.3 Million shares of OPKO Health Inc
CLAL GEMEL LTD. Bought 1.2 Million shares of OPKO Health Inc